NYSE ARCA | ETF
The fund invests, under normal circumstances, at least 80% of its net assets plus any borrowings for investment purposes (measured at the time of purchase) in equity investments inU. S. and non-U.S. health care companies.
The adviser generally intends to invest in companies that the adviser believes are aligned with key themes associated with innovation in health care, which include, but are not limited to, genomics, precision medicine, technology-enabled procedures, and digital healthcare.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 8.90% |
| BSX | Boston Scientific Corp | Healthcare | Medical Devices | 8.59% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 5.92% |
| UNH | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 5.89% |
| ABT | Abbott Laboratories | Healthcare | Medical Devices | 5.52% |
| ISRG | Intuitive Surgical Inc | Healthcare | Medical Instruments & Supplies | 5.48% |
| PODD | Insulet Corporation | Healthcare | Medical Devices | 5.21% |
| COO | The Cooper Companies, Inc | Healthcare | Medical Instruments & Supplies | 4.37% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.99% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 3.48% |
| LONN | Lonza Group AG | Healthcare | Diagnostics & Research | 3.42% |
| 0QIU | Novo Nordisk A/S Class B | 3.13% | ||
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 2.94% |
| 7741 | Hoya Cor | Healthcare | Medical Instruments & Supplies | 2.81% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 2.69% |
| VEEV | Veeva Systems Inc Class A | Healthcare | Health Information Services | 2.63% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 2.54% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 2.45% |
| HUM | Humana Inc | Healthcare | Healthcare Plans | 2.41% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.37% |